- AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.
LONDON (Thomson Reuters Foundation) - Some of the major health problems faced by women in developing countries are caused by "terrible" traditions that must be stopped, said the head of public health at the World Health Organisation (WHO).
- Of every $10 spent on healthcare in the U.S., almost 90 cents is due to smoking, a new analysis says.
- About a third of 15-year-olds in the UK have blacked out due to alcohol, a new survey indicates - and the rate rises to nearly three-quarters by the time they reach 19, researchers found.
- U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, providing the first competition for Gilead Sciences huge selling and expensive medicine for the liver-destroying virus.
CHICAGO - A child who arrived in Chicago with a fever was under observation on Friday at a city hospital to rule out the Ebola virus, hospital officials said.
GENEVA - Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information.
BEIRUT - One million people have been wounded during Syria's civil war and diseases are spreading as regular supplies of medicine fail to reach patients, the World Health Organization's Syria representative said.
MONROVIA - U.N. Secretary General Ban Ki-moon, starting a visit to Ebola-hit states in West Africa on Friday, urged their people to set aside traditional practices like washing the dead by hand so as to help end an epidemic that has killed nearly 7,000 people.
ZURICH/LONDON - Roche suffered a double blow on Friday as two clinical studies of drugs for breast cancer and Alzheimer's disease failed, sparking the biggest percentage fall in its stock in five years.